Interv Akut Kardiol 2011; 10(Suppl. D): 24-30

Myocardial fractional flow reserve

Martin Mates
Kardiologické oddělení, Komplexní kardiovaskulární centrum Nemocnice Na Homolce, Praha

Myocardial fractional flow reserve has become the only method used routinely to assess functional significance of coronary stenosis in the

cardiac catheter laboratory. It has been extensively studied and validated in different clinical situation over last 20 years. A recent large

multicenter study FAME found that a physiologically – guided coronary intervention was superior to the standard angiography-guided

approach in patients with multi-vessel disease. This review informs about methodology, limitations a clinical indication of fractional

flow reserve use.

Keywords: fractional flow reserve, coronary artery disease, percutaneous coronary intervention

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mates M. Myocardial fractional flow reserve. Interv Akut Kardiol. 2011;10(Suppl. D):24-30.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gruentzig A, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979; 301: 61-68. Go to original source... Go to PubMed...
    2. Uren NG, Melin JA, De Bruyne B. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994; 330: 1782-1788. Go to original source... Go to PubMed...
    3. Serruys PW, di Mario C, Piek J, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation. 1997; 96: 3369-3377. Go to original source... Go to PubMed...
    4. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993; 87: 1354-1367. Go to original source... Go to PubMed...
    5. De Bruyne B, Baudhuin T, Melin JA, et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 1994; 89: 1013-1022. Go to original source... Go to PubMed...
    6. Kushner FG, Hand M, Smith SC, Jr, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/ SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology J Am Coll Cardiol. 2009; 54: 2205-2241. Go to original source... Go to PubMed...
    7. Wijn W, Kohl P, Danchin N. Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2010; 31: 2501-2555. Go to original source... Go to PubMed...
    8. Komaru T, Kantsuka H, Shirato K. Coronary microcirculation. Physiology nad pharmacology. Pharmacology Therapeutics. 2000; 86: 217-261. Go to original source... Go to PubMed...
    9. Legalery P, Seronde MF, Meneveau N, Schiele F, Bassand JP. Measuring pressure-derived fractional flow reserve through four French diagnostic catheters. Am J Cardiol. 2003; 91: 1075-1078. Go to original source... Go to PubMed...
    10. De Bruyne B, Pijls NH, Barbato E, et al. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003; 107: 1877-1883. Go to original source... Go to PubMed...
    11. Parham WA, Bouhasin A, Ciaramita JP, Khoukaz S, Herrmann SC, Kern MJ. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation. 2004; 109: 1236-1243. Go to original source... Go to PubMed...
    12. Barbato E, Bartunek J, Aarnoudse W, et al. Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. Eur Heart J. 2004; 25: 2034-2039. Go to original source... Go to PubMed...
    13. Lindstaedt M, Bojara W, Holland-Letz T, et al. Adenosineinduced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access. Clin Res Cardiol. 2009; 98: 717-723. Go to original source... Go to PubMed...
    14. Casella G, Leibig M, Schiele TM, et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J. 2004; 148: 590-595. Go to original source... Go to PubMed...
    15. van der Voort PH, van Hagen E, Hendrix G, van Gelder B, Bech JW, Pijls NH. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn. 1996; 39: 120-125. Go to original source... Go to PubMed...
    16. Yoon MH, Tahk SJ, Yang HM, et al. Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement. Am Heart J. 2009; 157: 1050-1056. Go to original source... Go to PubMed...
    17. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996; 334: 1703-1708. Go to original source... Go to PubMed...
    18. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation. 1995; 92: 39-46. Go to original source... Go to PubMed...
    19. Pijls NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995; 92: 3183-3193. Go to original source... Go to PubMed...
    20. Bartunek J, Marwick TH, Rodrigues AC, et al. Dobutamineinduced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol. 1996; 27: 1429-1436. Go to original source... Go to PubMed...
    21. Chamuleau SA, Meuwissen M, van Eck-Smit BL, et al. Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease. J Am Coll Cardiol. 2001; 37: 1316-1322. Go to original source... Go to PubMed...
    22. Abe M, Tomiyama H, Yoshida H, Doba N. Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses: comparison with fractional flow reserve and coronary flow velocity reserve. Circulation. 2000; 102: 2365-2370. Go to original source... Go to PubMed...
    23. De Bruyne B, Pijls NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001; 104: 157-162. Go to original source... Go to PubMed...
    24. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007; 49: 2105-2111. Go to original source... Go to PubMed...
    25. Bech GJ, De Bruyne B, Bonnier HJ, et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol. 1998; 31: 841-847. Go to original source... Go to PubMed...
    26. Rieber J, Jung P, Schiele TM, et al. Safety of FFR-based treatment strategies: the Munich experience. Z Kardiol. 2002; 91(Suppl 3): 115-119. Go to original source... Go to PubMed...
    27. Mates M, Hrabos V, Hajek P, Rataj O, Vojacek J. Long-term follow-up after deferral of coronary intervention based on myocardial fractional flow reserve measurement. Coron Artery Dis. 2005; 16: 169-174. Go to original source... Go to PubMed...
    28. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; 360: 213-224. Go to original source... Go to PubMed...
    29. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010; 55: 2816-2821. Go to original source... Go to PubMed...
    30. Chamuleau SA, Meuwissen M, Koch KT, et al. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. Am J Cardiol. 2002; 89: 377-380. Go to original source... Go to PubMed...
    31. Bech GJ, Droste H, Pijls NH, et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart. 2001; 86: 547-552. Go to original source... Go to PubMed...
    32. Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009; 120: 1505-1512. Go to original source... Go to PubMed...
    33. De Bruyne B, Hersbach F, Pijls NH, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but, ,Normal" coronary angiography. Circulation. 2001; 104: 2401-2406. Go to original source... Go to PubMed...
    34. Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol. 2005; 46: 633-637. Go to original source... Go to PubMed...
    35. Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J. 2008; 29: 726-732. Go to original source... Go to PubMed...
    36. Bech GJ, De Bruyne B, Akasaka T, et al. Coronary pressure and FFR predict long-term outcome after PTCA. Int J Cardiovasc Intervent. 2001; 4: 67-76. Go to original source... Go to PubMed...
    37. Pijls NH, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002; 105: 2950-2954. Go to original source... Go to PubMed...
    38. Ntalianis A, Sels JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010; 3: 1274-1281. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.